Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Hauer, AC; Haiden, N; Male, C; Pietschnig, B; Repa, A; Pollak, A; Rock, I; Scholl-Burgi, S; Karall, D; Sperl, W; Weghuber, D; Zwiauer, K; .
Vitamin K prophylaxis in newborns - update 2013. Recommendations of the Committee on Nutrition of the Austrian Society of Pediatrics (OGKJ).
MONATSSCHR KINDERHEILK. 2014; 162(1): 64-67.
Doi: 10.1007/s00112-013-3030-4
Web of Science
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
- Hauer Almuthe
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Vitamin K prophylaxis administered to newborns prevents rare but potentially serious and sometimes fatal hemorrhage due to vitamin K deficiency. For many years in Austria it has been recommended that all newborns should receive vitamin K and the present recommendations update in particular practical issues and questions. For healthy term newborns and orally fed preterm infants vitamin K should be given orally immediately after birth, after 4-6 days and after 4-6 weeks. Preterm infants with a birth weight less than 1,000 g should receive 500 A mu g vitamin K administered intramuscularly or intravenously after birth, preterm infants with a birth weight between 1,000 and 1,500 g should initially receive 1,000 A mu g. For both groups it is recommended that afterwards 8-10 A mu g/kg body weight/day should be administered parenterally. At the age of 4 weeks or prior to discharge all infants should again receive an oral prophylaxis of 2 mg vitamin K. For mothers on medications interfering with vitamin K metabolism (e.g. antiepileptic drugs, oral anticoagulants, antibiotics or antituberculostatics) 20 mg vitamin K is recommended during the final 15-30 days of pregnancy.
- Find related publications in this database (Keywords)
- Vitamin K
- Vitamin K prophylaxis
- Hemorraghic disorders
- Newborn infants
- Preterm births